Morphological response of axotomized septal neurons to nerve growth factor
- PMID: 3361001
- DOI: 10.1002/cne.902690112
Morphological response of axotomized septal neurons to nerve growth factor
Abstract
Septal efferent fibers from the neurons in the medial septal nucleus are destroyed by fimbria-fornix aspirative lesion. In the present study we used quantitative morphometric techniques to evaluate the response of these axotomized septal neurons to a constant infusion of nerve growth factor (NGF). By 2 weeks following the lesion, approximately 75% of the cholinergic neurons had degenerated in the untreated rats. The remaining cholinergic neurons showed few signs of the effect of the lesion when stained for a polyclonal antibody to ChAT and examined in 40-micron-thick sections. In 1-micron-thick sections the remaining ChAT-immunoreactive (IR) neurons also appeared no different from the intact ChAT neurons. However, non-ChAT-IR neurons had a shrunken nucleus, while all other morphometric parameters appeared normal. NGF infusion protected most of the ChAT-IR neurons from degenerating. The saved neurons had the same parameters as the undamaged ChAT-IR neurons when examined in either 40-micron- or 1-micron-thick sections. In addition, the shrunken appearance of the non-ChAT-IR neurons' nuclei was avoided by the NGF infusions. Enlarged ChAT-IR processes were evident in the dorsolateral quadrant of the septum following damage to the fimbria-fornix. NGF-infusions prevented the formation of these processes. Instead, in the treated animals the dorsal lateral quadrant contained a dense plexus of fine ChAT-IR varicosities. Taken together these results demonstrate that NGF not only can protect the cholinergic neurons from axotomy-induced degeneration but can also cause the saved neurons to maintain the same morphometric appearance as intact ChAT-IR neurons.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Development of cholinergic pedunculopontine neurons in vitro: comparison with cholinergic septal cells and response to nerve growth factor, ciliary neuronotrophic factor, and retinoic acid.J Neurosci Res. 1988 Oct-Dec;21(2-4):365-75. doi: 10.1002/jnr.490210228. J Neurosci Res. 1988. PMID: 3216429
-
Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitro.J Neurosci Res. 1988 Oct-Dec;21(2-4):352-64. doi: 10.1002/jnr.490210227. J Neurosci Res. 1988. PMID: 3216428
-
Response of septal cholinergic neurons to axotomy.J Comp Neurol. 1987 Oct 15;264(3):421-36. doi: 10.1002/cne.902640309. J Comp Neurol. 1987. PMID: 3680637
-
Role of NGF in axotomy-induced c-Jun expression in medial septal cholinergic neurons.Int J Dev Neurosci. 1998 Nov-Dec;16(7-8):691-703. doi: 10.1016/s0736-5748(98)00079-3. Int J Dev Neurosci. 1998. PMID: 10198817 Review.
-
NGF-dependent sprouting and regeneration in the hippocampus.Prog Brain Res. 1990;83:357-70. doi: 10.1016/s0079-6123(08)61262-5. Prog Brain Res. 1990. PMID: 2203102 Review.
Cited by
-
Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells.Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1632-6. doi: 10.1073/pnas.91.5.1632. Proc Natl Acad Sci U S A. 1994. PMID: 8127857 Free PMC article.
-
TrkA activation is sufficient to rescue axotomized cholinergic neurons.Neuron. 1996 Mar;16(3):653-63. doi: 10.1016/s0896-6273(00)80084-7. Neuron. 1996. PMID: 8785062 Free PMC article.
-
Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons.Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2324-8. doi: 10.1073/pnas.91.6.2324. Proc Natl Acad Sci U S A. 1994. PMID: 8134395 Free PMC article.
-
Cholinotrophic basal forebrain connectome dysfunction in Down syndrome with and without dementia.iScience. 2025 Jul 1;28(8):113041. doi: 10.1016/j.isci.2025.113041. eCollection 2025 Aug 15. iScience. 2025. PMID: 40822354 Free PMC article.
-
Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA.J Neurosci. 2004 Sep 15;24(37):8009-18. doi: 10.1523/JNEUROSCI.1508-04.2004. J Neurosci. 2004. PMID: 15371501 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources